Enrolling
Placebo-controlled randomized trial of tecovirimat in non-hospitalized patients with Mpox: Canadian Feasibility Study
Learn MoreReporting
Optimizing HIV prevention for sexual and gender minorities seeking mental health supports: A feasibility study
Learn MoreEnrolling
A randomized trial of doxycycline chemoprophylaxis for the prevention of sexually transmitted infections in gay, bisexual and other men who have sex with men (gbMSM)
Learn MoreStart-up
Development and validation of an anal cancer screening algorithm in HIV-positive men who have sex with men
Learn MoreReporting
A randomized, placebo-controlled trial of oral doxycycline for the prevention of syphilis in HIV-positive men who have sex with men (MSM)
Learn MoreEnrolling
A multicenter, randomized controlled trial of the efficacy, safety and immunogenicity of the 9-valent human papillomavirus (HPV) vaccination in preventing recurrence of high-grade anal dysplasia in HIV-positive men who have sex with men (MSM)
Learn MoreStart-up
Contextual Analysis of Urban and Rural Programs and Supports for First Nations and Métis People Living with HIV and other STBBIs
Learn MoreReporting
Development of a Rural Model (DRUM) for Integrated Shared Care in First Nation and Métis Communities
Learn MoreOngoing
HIV Prevention for Gay, Bisexual, and other Men Who Have Sex with Men
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
